Global Eye Drops (Prescription vs. OTC) Markets, Analysis, Competition, Forecast and Opportunities, 2017-2021 & 2022-2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Eye Drops Market by Type (Prescription or OTC), by Drug Class (Anti-Allergy, Anti-Glaucoma, Anti-Inflammatory, Anti-VEGF and Others), by Indication Disease, By Distribution Channel, By Region, Competition Forecast and Opportunities, Report 2027″ has been added to from ResearchAndMarkets.com offer.

Global Eye Drops Market was valued at USD 13530 Million in 2021 and is projected to grow with a CAGR of 6.46% during the forecast period to reach a market value of USD 19758 Million by 2027.

The market is expected to grow due to the increase in eye infection cases in the population. The higher prevalence of eye diseases such as dry eyes, redness, itchy eyes, conjunctivitis, pain, glaucoma, etc. will further drive the growth of the global eye drops market over the next five years.

Excessive screen time and penetration of smart phones, laptops, TVs and electronics further support the growth of the global eye drops market over the next five years. Governments around the world are actively investing in the health sector and increasing the production of pharmaceutical and therapeutic products in recent years.

Growing import and export of pharmaceutical and therapeutic products such as eye drops is further contributing to the growth of the global eye drops market over the next five years. Additionally, consumers across the country have been spending on healthcare services to get excellent patient care. Rising disposable income of the people is also supporting the growth of the market.

Technological advancements in product manufacturing, expanding logistics sector with easy distribution of products are further contributing to the growth of the global eye drops market over the forecast period.

Based on type, the market is further differentiated into prescription and over-the-counter. Prescription eye drops are expected to hold the largest market revenue shares and dominate the market segment over the next five years owing to the increase in eye disease cases.

Rising cases of diabetes and hence higher risks of getting eye diseases, impaired vision are also contributing to the growth of the segment. Over-the-counter eye drops are expected to see the fastest growth due to the growing trend of consumers self-treating their burning and red eye issues, etc.

Increase in common itchy and dry eyes due to prolonged screen times is also contributing to the growth of the sub-segment as well as the growth of the global eye drops market in the next five years.

Goal of the study:

  • To analyze historical market size growth of global eye drops market from 2017 to 2021.

  • Estimate and forecast the market size of Global Eye Drops Market from 2022E-2027F and the growth rate till 2027F.

  • To classify and forecast the global eye drops market based on type, drug class, disease indication, distribution channel, competitive landscape, and regional distribution.

  • To identify the dominant region or segment in the global eye drops market.

  • Identify drivers and challenges in the global eye drops market.

  • Examine competitive developments such as expansions, new product launches, mergers and acquisitions, and others in the global Eye Drops Market.

  • To identify and analyze the profile of key players operating in the global Eye Drops Market.

  • To identify the key sustainable strategies adopted by market players in the global Eye Drops Market.

Key Market Players in Global Eye Drops Market

  • Johnson & Johnson Inc.

  • Genentech, Inc. (Roche)

  • Alcon inc.

  • Pfizer, Inc.

  • Bausch Health Companies, Inc.

  • Bayer Corporation

  • Allergan, Inc. (AbbVie)

  • Abbott Laboratories Inc.

  • KC Pharmaceuticals, Inc.

  • Akorn, Inc.

Report Scope:

Years considered for this report:

  • Historical years: 2017- 2020

  • Base year: 2021

  • Estimated year: 2022E

  • Forecast Period: 2023F – 2027F

Eye Drops Market, By Type:

  • Prescription

  • Over the counter

Eye Drops Market, By Drug Class:

  • Anti-allergy

  • Anti-glaucoma

  • Anti-inflammatory

  • Anti-VEGF

  • Others

Eye Drops Market, By Disease Indication:

  • Eye allergy

  • Glaucoma

  • Eye infections

  • Dry eye diseases

  • Retinal disorders

Eye Drops Market, By Distribution Channel:

  • Hospitals Pharmacy

  • Retail pharmacy

  • Online pharmacy

Eye Drops Market, By Region:

  • North America

  • United States

  • Canada

  • Mexico

  • Europe

  • Russian Federation

  • UK

  • Germany

  • France

  • Spain

  • Italy

  • Asia Pacific

  • China

  • India

  • Japan

  • Australia

  • South Korea

  • Indonesia

  • South America

  • Brazil

  • Argentina

  • Colombia

  • Middle East and Africa

  • Turkey

  • South Africa

  • Saudi Arabia

  • United Arab Emirates

  • Kuwait

For more information on this report visit https://www.researchandmarkets.com/r/igly5

Comments are closed.